Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI method could make lung cancer treatment more precise

NCT ID NCT06322329

Knowledge-focused Sponsor: Region Stockholm Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether dynamic MRI can better track lung tumor movement during breathing compared to standard CT scans. 150 patients receiving stereotactic body radiotherapy for lung tumors will get an extra MRI scan. If MRI proves more accurate, it could help doctors plan radiation treatments that hit tumors more precisely and spare healthy tissue.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dynamic MRI scan
What this could lead to
If successful, this could lead to more precise radiotherapy planning for lung cancer, reducing damage to healthy tissue while ensuring tumors are fully treated.
What could go wrong
This is an early observational study, not a treatment trial. The new MRI method may not prove better than current CT scans, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Mar 2036

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Accepted for SBRT treatment of one or more caudally situated lung targets (NSCLC or metastases), i.e. below the carina. * Age ≥ 18 years * Adequate clinical condition to maintain immobilised position for at least 30 minutes * Adequate Swedish skills and cognitive function to understand study information and to fill in the questionnaire Exclusion Criteria: * Pregnancy or breastfeeding, or planned pregnancy or breastfeeding, during treatment * Contraindication for MRI examination * Otherwise incapable of participating in study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung tumor are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung tumor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Karolinska University Hospital

    RECRUITING

    Stockholm, 17176, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.